DAVINA BETTS: Open Payments
NPI 1558494724 · BOURBONNAIS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,029 in 91 payments from 19 companies in 2025. Trend: 2023 $1,981 · 2024 $2,718 · 2025 $2,029
Food & beverage: $2,029
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $609 |
| Novo Nordisk Inc | 14 | $289 |
| Radius Health, Inc. | 10 | $197 |
| ABBVIE INC. | 9 | $174 |
| Lilly USA, LLC | 10 | $167 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $129 |
| GlaxoSmithKline, LLC. | 6 | $121 |
| Amgen Inc. | 4 | $70 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| PFIZER INC. | 2 | $36 |
Products named: JARDIANCE, AIRSUPRA, FARXIGA, Tymlos, BREZTRI, VRAYLAR, Ozempic, Wegovy.
Industry payments across IL — which companies pay providers there.
